Volume 55, Issue 4 pp. 601-604
Cases of the Month

Neurological Nuance: Hodgkin lymphoma presenting with Guillain–BarrÉ syndrome

Dustin Anderson MD, PhD

Dustin Anderson MD, PhD

Department of Medicine (Neurology), University of Alberta, 7-132A Clinical Sciences Building, 11350-83 Avenue, Edmonton, Alberta, T6G 2G3 Canada

Search for more papers by this author
Grayson Beecher MD

Grayson Beecher MD

Department of Medicine (Neurology), University of Alberta, 7-132A Clinical Sciences Building, 11350-83 Avenue, Edmonton, Alberta, T6G 2G3 Canada

Search for more papers by this author
Trevor A. Steve MD

Trevor A. Steve MD

Department of Medicine (Neurology), University of Alberta, 7-132A Clinical Sciences Building, 11350-83 Avenue, Edmonton, Alberta, T6G 2G3 Canada

Search for more papers by this author
Ho Jen MD

Ho Jen MD

Department of Radiology & Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada

Search for more papers by this author
Richard Camicioli MD

Richard Camicioli MD

Department of Medicine (Neurology), University of Alberta, 7-132A Clinical Sciences Building, 11350-83 Avenue, Edmonton, Alberta, T6G 2G3 Canada

Search for more papers by this author
Douglas W. Zochodne MD

Corresponding Author

Douglas W. Zochodne MD

Department of Medicine (Neurology), University of Alberta, 7-132A Clinical Sciences Building, 11350-83 Avenue, Edmonton, Alberta, T6G 2G3 Canada

Correspondence to: D.W. Zochodne; e-mail: [email protected]Search for more papers by this author
First published: 18 October 2016
Citations: 7

ABSTRACT

Introduction

Hodgkin lymphoma (HL) is a common lymphoid malignancy rarely associated with Guillain–Barré syndrome (GBS). In most cases, GBS does not precede HL.

Methods

We describe a patient with acute inflammatory demyelinating polyneuropathy who fulfilled criteria for GBS that heralded undiagnosed HL.

Results

Cerebrospinal fluid (CSF) studies revealed albuminocytologic dissociation with significant protein elevation (250 mg/dl). The patient worsened during intravenous immunoglobulin (IVIg) therapy. Constitutional symptoms with elevated inflammatory markers prompted further investigation, and imaging revealed an anterior mediastinal mass confirmed on biopsy to be HL. Chemotherapy yielded early clinical improvement.

Conclusions

GBS preceding HL is rare, and this case highlights the importance of considering HL in the setting of GBS. Marked elevations in CSF protein, ongoing deterioration despite administration of IVIg, and constitutional symptoms with elevated inflammatory markers may be clues to possible HL-induced GBS. Muscle Nerve 55: 601–604, 2017

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me